Irinotecan-Induced Skin Dryness Is Ameliorated By Orally Administered High-Dose Vitamin C In Mice
Authors Nakanishi K, Goto K, Kondo K, Hiramoto K, Ooi K
Received 31 July 2019
Accepted for publication 30 September 2019
Published 9 October 2019 Volume 2019:11 Pages 109—114
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Professor Bal Lokeshwar
Kentaro Nakanishi,1 Kenji Goto,1 Kanako Kondo,1,2 Keiichi Hiramoto,1 Kazuya Ooi1
1Department of Pharmaceutical Science, Suzuka University of Medical Science, Suzuka, Mie 513-8670, Japan; 2Department of Pharmacy, Kuwana City Medical Center, Kuwana, Mie 511-0061, Japan
Correspondence: Kazuya Ooi
Department of Pharmaceutical Science, Suzuka University of Medical Science, Suzuka, Mie 513-8670, Japan
Background: Vitamin C plays a part in various roles in the human body. In this study, we examined the effect of oral administration of high-dose vitamin C on the skin dryness induced by irinotecan.
Methods: To establish the experimental model of irinotecan-induced skin dryness, the drug was intraperitoneally administered for four consecutive days. Simultaneously, oral administration of high-dose vitamin C (4 g/kg) was continued for 4 days.
Results: High-dose vitamin C administration ameliorated the skin dryness induced by irinotecan. The expression of caspase-3 and caspase-9, reactive oxygen species, and the number of TUNEL-positive cells increased in the skin of irinotecan-treated mice but were lowered by high-dose vitamin C administration. In contrast, fibroblasts and collagen type I decreased in the skin of the irinotecan-treated mice but was increased by high-dose vitamin C administration.
Conclusion: These results suggested that high-dose vitamin C administration can improve the skin dryness induced by irinotecan.
Keywords: apoptosis, collagen type I, irinotecan, reactive oxygen species, vitamin C
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]